Navidea to Participate in the BTIG Emerging Technologies in Healthcare Diagnostics Investor Conference September 30th
September 29 2014 - 3:36PM
Business Wire
Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB), a
biopharmaceutical company focused on precision diagnostic
radiopharmaceuticals, today announced that the Company will
participate in the BTIG Emerging Technologies in Healthcare
Diagnostics investor conference taking place September 29th and
30th in New York.
Interim Chief Executive Officer Michael Goldberg, M.D., will
participate in the following panels on Tuesday, September 30th:
- Cell Specific Imaging/Biopsy
Assistance
- Innovations in Diagnosing
Alzheimer’s
- Laboratory vs. Hospital Launch
The conference is organized as a series of panel discussions
designed to inform investors on trends, technologies, and
organizations shaping the healthcare diagnostics industry. As a
result of the format, a webcast will not be available.
About Navidea Biopharmaceuticals, Inc.Navidea
Biopharmaceuticals, Inc. (NYSE MKT: NAVB) is a biopharmaceutical
company focused on the development and commercialization of
precision diagnostics and radiopharmaceutical agents. Navidea is
developing multiple precision diagnostic products and platforms
including Manocept™, NAV4694, NAV5001, and NAV1800 (RIGScan™), to
help identify the sites and pathways of undetected disease and
enable better diagnostic accuracy, clinical decision-making and,
ultimately, patient care. Lymphoseek® (technetium Tc 99m
tilmanocept) Injection, Navidea’s first commercial product from the
Manocept platform, was approved by the FDA in March 2013. Navidea’s
strategy is to deliver superior growth and shareholder return by
bringing to market novel radiopharmaceutical agents and advancing
the Company’s pipeline through selective acquisitions, global
partnering and commercialization efforts. For more information,
please visit www.navidea.com.
Navidea BiopharmaceuticalsBrent Larson, Executive VP & CFO,
614-822-2330orSharon Correia, Associate Director, Corporate
Communications, 978-655-2686
Navidea Biopharmaceuticals (AMEX:NAVB)
Historical Stock Chart
From Aug 2024 to Sep 2024
Navidea Biopharmaceuticals (AMEX:NAVB)
Historical Stock Chart
From Sep 2023 to Sep 2024